Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis
出版年份 2021 全文链接
标题
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis
作者
关键词
Diffuse large B-cell lymphoma, Berberine, CD47, Phagocytosis, Immunochemotherapy
出版物
BIOCHEMICAL PHARMACOLOGY
Volume 188, Issue -, Pages 114576
出版商
Elsevier BV
发表日期
2021-04-28
DOI
10.1016/j.bcp.2021.114576
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma
- (2021) Tan Sang et al. CANCER GENE THERAPY
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study
- (2020) Ying-Xuan Chen et al. Lancet Gastroenterology & Hepatology
- Combination of CD47 and SIRPα constituting the "don't eat me signal" is a prognostic factor in diffuse large B‐cell lymphoma
- (2020) Ryo Kazama et al. CANCER SCIENCE
- Immunotherapy in Hodgkin and Non-Hodgkin Lymphoma: Innate, Adaptive and Targeted Immunological Strategies
- (2020) Aung M. Tun et al. CANCER TREATMENT REVIEWS
- CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma
- (2020) Zhi-Hui Wang et al. OncoTargets and Therapy
- CD47: the next checkpoint target for cancer immunotherapy
- (2020) Ridong Feng et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
- (2020) Juan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
- (2020) Xiangxiang Zhou et al. Journal of Hematology & Oncology
- Role of CD47 in Hematological Malignancies
- (2020) Entsar Eladl et al. Journal of Hematology & Oncology
- Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism
- (2020) Jingjing Liu et al. JOURNAL OF PROTEOME RESEARCH
- Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
- (2020) Yang Liu et al. Acta Pharmaceutica Sinica B
- Low-Dose Berberine Attenuates the Anti-Breast Cancer Activity of Chemotherapeutic Agents via Induction of Autophagy and Antioxidation
- (2020) Bing Han et al. Dose-Response
- In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects
- (2020) Wenyu Ma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The functions and clinical significance of circRNAs in hematological malignancies
- (2020) Xiangxiang Zhou et al. Journal of Hematology & Oncology
- Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis
- (2020) Luping Liu et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
- (2020) Demet Candas-Green et al. Nature Communications
- A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
- (2019) Da Liu et al. Frontiers in Pharmacology
- Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis
- (2019) Wei Dai et al. MEDICAL SCIENCE MONITOR
- Industry corner: perspectives and controversies
- (2019) C H Takimoto et al. ANNALS OF ONCOLOGY
- Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
- (2019) Christian M. Schürch et al. THYROID
- Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
- (2019) Jun Lu et al. BMC CANCER
- Cell-specific pattern of berberine pleiotropic effects on different human cell lines
- (2018) Alessandro Agnarelli et al. Scientific Reports
- Diverse Functions of Macrophages in Different Tumor Microenvironments
- (2018) Ming Yang et al. CANCER RESEARCH
- Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells
- (2018) Sindy Hu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
- (2018) Eric Hatterer et al. mAbs
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma
- (2018) Qian Hu et al. Frontiers in Pharmacology
- Is CD47 an innate immune checkpoint for tumor evasion?
- (2017) Xiaojuan Liu et al. Journal of Hematology & Oncology
- Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma
- (2017) Xiangxiang Zhou et al. Journal of Hematology & Oncology
- Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition
- (2017) Dong Hou et al. Cell Death & Disease
- The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
- (2017) Lynh Nguyen et al. Genes
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells
- (2016) Chunjie Wen et al. Molecular Medicine Reports
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
- (2016) K. Weiskopf et al. Cancer Immunology Research
- Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
- (2015) Meng Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Berberine Induces Senescence of Human Glioblastoma Cells by Downregulating the EGFR-MEK-ERK Signaling Pathway
- (2014) Q. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
- (2013) Yuhua Wang et al. MOLECULAR THERAPY
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51
- (2011) Qiao Liu et al. PLoS One
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started